MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the year ending 2025-12-31.

Cash Flow Overview

Free Cash flow
-$190,454K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of inve...
    • Stock-based compensation
    • Depreciation and amortization of...
    • Others
Negative Cash Flow Breakdown
    • Purchases of investments
    • Accounts payable and accrued exp...
    • Accretion of discount on investm...
    • Others

Cash Flow
2025-12-31
Net loss
-223,123
Depreciation and amortization of property and equipment
8,871
Amortization of finance lease right of use asset
2,154
Impairment of operating lease right-of-use asset
262
Stock-based compensation
37,059
Accretion of discount on investments, net
6,974
Change in fair value of warrant liabilities
0
Prepaid expenses and other assets
-2,089
Accounts payable and accrued expenses
-10,351
Operating lease liabilities and right of use assets, net
45
Finance lease liability
35
Other liabilities
-81
Net cash used in operating activities
-190,014
Purchases of investments
276,553
Proceeds from maturities of investments
380,760
Purchases of property and equipment
440
Net cash provided by investing activities
103,767
Issuance of common stock, net of issuance costs-Public Offering
0
Issuance of common stock pursuant to exercise of stock options
0
Return of related party short-swing profits
215
Repurchase of restricted stock units to satisfy tax withholding
67
Net cash provided by financing activities
148
Net change in cash, cash equivalents and restricted cash
-86,099
Cash, cash equivalents and restricted cash at beginning of period
164,997
Cash, cash equivalents and restricted cash at end of period
78,898
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof investments$380,760K Return of related partyshort-swing profits$215K Net cash provided byinvesting activities$103,767K Net cash provided byfinancing activities$148K Canceled cashflow$276,993K Canceled cashflow$67K Net change in cash,cash equivalents and...-$86,099K Canceled cashflow$103,915K Stock-based compensation$37,059K Depreciation andamortization of property and...$8,871K Amortization of finance leaseright of use asset$2,154K Prepaid expenses andother assets-$2,089K Impairment of operatinglease right-of-use...$262K Operating leaseliabilities and right of use...$45K Finance lease liability$35K Purchases of investments$276,553K Purchases of property andequipment$440K Repurchase of restrictedstock units to satisfy...$67K Net cash used inoperating activities-$190,014K Canceled cashflow$50,515K Net loss-$223,123K Accounts payable andaccrued expenses-$10,351K Accretion of discount oninvestments, net$6,974K Other liabilities-$81K

ROCKET PHARMACEUTICALS, INC. (RCKTW)

ROCKET PHARMACEUTICALS, INC. (RCKTW)